Ruste, Leonora L.
HRN: 06-70-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2024
10/17/2024
IV
500mg
Every 8 Hours
Thickly Meconium Stained Amniotic Fluid; FDU
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes